Cardiomyopathy: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
{{CMG}}; {{AE}} {{CZ}}, {{RT}} | {{CMG}}; {{AE}} {{CZ}}, {{RT}} | ||
== [[Cardiomyopathy overview|Overview]] == | |||
==[[ Cardiomyopathy historical perspective| Historical Perspective]]== | |||
== [[Cardiomyopathy classification|Classification]] == | |||
== [[Cardiomyopathy pathophysiology|Pathophysiology]] == | |||
== [[Cardiomyopathy causes|Causes]] == | |||
== [[Cardiomyopathy differential diagnosis|Differentiating Cardiomyopathy from other Diseases]] == | |||
== [[Cardiomyopathy epidemiology and demographics|Epidemiology and Demographics]] == | |||
==[[Cardiomyopathy risk factors | Risk Factors]]== | |||
== [[Cardiomyopathy natural history, complications and prognosis|Natural History, Complications and Prognosis]] == | |||
== Diagnosis == | |||
[[Cardiomyopathy criteria| Diagnostic Criteria]] | | |||
[[Cardiomyopathy history and symptoms|History and Symptoms]] | [[Cardiomyopathy physical examination|Physical Examination]] | [[Cardiomyopathy laboratory findings|Laboratory Findings]] | [[Cardiomyopathy electrocardiogram|Electrocardiogram]] | [[Cardiomyopathy chest x ray | Chest X Ray]] | [[Cardiomyopathy CT| CT]] | [[Cardiomyopathy MRI|MRI]] | [[Cardiomyopathy echocardiography or ultrasound|Echocardiography]] | [[Cardiomyopathy other imaging findings| Other Imaging Findings]] | [[Cardiomyopathy other diagnostic studies|Other Diagnostic Studies]] | |||
== Treatment == | |||
[[Cardiomyopathy medical therapy|Medical Therapy]] | [[Cardiomyopathy surgery|Surgery]] | [[Cardiomyopathy primary prevention|Primary Prevention]] | [[Cardiomyopathy cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Cardiomyopathy future or investigational therapies|Future or Investigational Therapies]] | |||
== Case Studies == | |||
: [[Cardiomyopathy case study one|Case #1]] | |||
------- | |||
==[[Cardiomyopathy overview|Overview]]== | ==[[Cardiomyopathy overview|Overview]]== | ||
Revision as of 15:03, 30 August 2012
For patient information click here
| Cardiomyopathy | |
 | |
|---|---|
| Opened left ventricle of heart shows a thickened, dilated left ventricle with subendocardial fibrosis manifested as increased whiteness of endocardium {Autopsy findings}. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.0 |
| ICD-9 | 425.4 |
| DiseasesDB | 2137 |
| MeSH | D009202 |
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Overview
Classification
Pathophysiology
Epidemiology and Demographics
Risk Factors
Causes
- Dilated cardiomyopathy
- Hypertrophic obstructive cardiomyopathy
- Noncompaction cardiomyopathy
- Tachycardia induced cardiomyopathy
Differentiating Cardiomyopathy from other Diseases
Natural History, Complications and Prognosis
Treatment
de:Kardiomyopathie nl:Cardiomyopathie no:Kardiomyopati simple:Cardiomyopathy sr:Кардиомиопатија sv:Hjärtmuskelsjukdom